Frankfurt - Delayed Quote EUR
IN8bio, Inc. (6JH.F)
As of 3:29 PM GMT+1. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 10.09M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BRANDT PETER C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 4, 2024 |
ROEMER ALAN S. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 4, 2024 |
HO WILLIAM TAI WEI Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 4, 2024 |
MCCALL PATRICK CPA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 4, 2024 |
ROCHLIN KATE PH.D. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 4, 2024 |
BRANDT PETER C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
ROEMER ALAN S. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
EPPERLY CORINNE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
HO WILLIAM TAI WEI Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
LAMB LAWRENCE S. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
MCCALL PATRICK CPA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
GOSWAMI TRISHNA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
ROCHLIN KATE PH.D. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
GRAFF JEREMY R. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
GRAFF JEREMY R. Director | Purchase at price 0.95 per share. | Direct | 2,375 | Sep 13, 2023 |
MCCALL PATRICK CPA Chief Financial Officer | Purchase at price 1.03 per share. | Direct | 1,030 | Aug 25, 2023 |
HO WILLIAM TAI WEI Chief Executive Officer | Purchase at price 1.05 per share. | Direct | 24,990 | Aug 24, 2023 |
FLETCHER AARON G.L. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.48 per share. | Indirect | 185,912 | Dec 12, 2022 |
KREIS LESLIE W JR Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.48 per share. | Indirect | 185,912 | Dec 12, 2022 |
Related Tickers
SFY0.MU Theriva Biologics Inc. R
1.3600
0.00%
6C1.F CytomX Therapeutics, Inc.
0.8400
+7.35%
6C1.SG CytomX Therapeutics Inc
0.9095
-1.57%
BT1.F BioSenic S.A.
0.0114
-0.87%
6C1.BE CytomX Therapeutics Inc
0.9670
+4.20%
6C1.DU CytomX Therapeutics Inc
0.9150
-0.92%
APTA.L Aptamer Group plc
0.2700
+17.39%
VAL.L ValiRx plc
1.4500
-4.92%
NRXPW NRx Pharmaceuticals, Inc.
0.0631
0.00%
HSTO Histogen Inc.
0.2100
-1.18%